Start:
November 2013
End:
November 2017
Enrollment:
250
One of the most significant challenges of dementia care is neuropsychiatric symptoms, including agitation, a common behavior that is associated with increased health care costs, reduced quality of life, heightened caregiver burden, disease acceleration, and nursing home placement. In this clinical trial, a nonpharmacologic, person-centered intervention, the Tailored Activity Program (TAP), will be tested. If proven cost-effective, TAP has potential to transform clinical practice by offering a proven nonpharmacologic treatment for agitation of people with dementia at home.
Minimum Age: 21 Years
Maximum Age: N/A
Inclusion criteria pertain to both the person with dementia and the caregiver. If either is eligible but the other is not, they will not be enrolled.
People with Dementia
Caregivers
People with Dementia
Caregivers
Both Groups
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Lead: Johns Hopkins University
Collaborator Sponsor
Source: ClinicalTrials.gov ID: NCT01892579
An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health